These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 28013210)

  • 1. Castleman disease and lymphocytic interstitial pneumonia: a complex diagnostic and management challenge.
    Bayes HK; McInnes IB; Chalmers GW
    Rheumatology (Oxford); 2017 Apr; 56(4):665-668. PubMed ID: 28013210
    [No Abstract]   [Full Text] [Related]  

  • 2. X-linked Inhibitor of Apoptosis Complicated by Granulomatous Lymphocytic Interstitial Lung Disease (GLILD) and Granulomatous Hepatitis.
    Steele CL; Doré M; Ammann S; Loughrey M; Montero A; Burns SO; Morris EC; Gaspar B; Gilmour K; Bibi S; Shendi H; Devlin L; Speckmann C; Edgar DM
    J Clin Immunol; 2016 Oct; 36(7):733-8. PubMed ID: 27492372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successfully treated multicentric Castleman's disease with renal thrombotic microangiopathy using rituximab and corticosteroid.
    Lee JP; Kim DK; Oh DY; Paik JH; Moon KC; Kim S; Kim YS
    Clin Nephrol; 2011 Feb; 75(2):165-70. PubMed ID: 21255547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [PET-CT documented remission of multicentric Castleman disease after treatment with rituximab: case report and review].
    Adam Z; Szturz P; Koukalová R; Řehák Z; Pour L; Krejčí M; Šmardová L; Eid M; Volfová P; Čermáková Z; Křen L; Sokol F; Hanke I; Michalková E; Král Z; Mayer J
    Vnitr Lek; 2015 Mar; 61(3):251-9. PubMed ID: 25873122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful treatment with rituximab in a Japanese patient with systemic sclerosis-associated interstitial lung disease resistant to oral steroid and cyclophosphamide.
    Numajiri H; Yoshizaki A; Ebata S; Fukasawa T; Yamashita T; Takahashi T; Taniguchi T; Asano Y; Sato S
    J Dermatol; 2018 Jun; 45(6):e140-e141. PubMed ID: 29265579
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of unicentric Castleman disease with neoadjuvant rituximab.
    Bandera B; Ainsworth C; Shikle J; Rupard E; Roach M
    Chest; 2010 Nov; 138(5):1239-41. PubMed ID: 21051400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multicentric Castleman disease of hyaline vascular variant presenting with unusual systemic manifestations: a case report.
    Basnayake BMDB; Wazil AWM; Kannangara T; Ratnatunga NVI; Hewamana S; Ameer AM
    J Med Case Rep; 2017 May; 11(1):135. PubMed ID: 28501028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful use of rituximab in glomerular basement membrane nephritis associated with HIV interstitial nephritis secondary to Castleman disease
.
    Calabro N; Henriksen K; Lim SH; Kerns E
    Clin Nephrol; 2018 Jun; 89(6):469-473. PubMed ID: 29424337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Castleman tumor as a rare differential diagnosis of cervical space-occupying lesion].
    Rübberdt A; Memming M; Brennecke J; Jähne J
    Chirurg; 2001 Aug; 72(8):965-8. PubMed ID: 11554144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unprecedented success of rituximab therapy for prednisolone- and immunosuppressant-resistant systemic sclerosis-associated interstitial lung disease.
    Ebata S; Yoshizaki A; Fukasawa T; Nakamura K; Yamashita T; Miura S; Saigusa R; Ichimura Y; Takahashi T; Hirabayashi M; Taniguchi T; Akamata K; Asano Y; Sato S
    Scand J Rheumatol; 2017 May; 46(3):247-252. PubMed ID: 27900875
    [No Abstract]   [Full Text] [Related]  

  • 11. Idiopathic multicentric Castleman disease of TAFRO subtype.
    Godfrey K; Harris E; Moss H; Martin-Cabrera P
    Br J Haematol; 2022 Feb; 196(3):461. PubMed ID: 34618353
    [No Abstract]   [Full Text] [Related]  

  • 12. Castleman-Kojima disease in a South Asian adolescent.
    Koduri PR; Parvez M; Kaza S; Pappu P; Anuradha S
    J Clin Exp Hematop; 2014; 54(2):163-6. PubMed ID: 25318950
    [No Abstract]   [Full Text] [Related]  

  • 13. Castleman disease presenting with ophthalmic signs and symptoms.
    Kurokawa T; Suzuki S; Kawaguchi K; Fujisawa N; Yoshimura N
    Am J Ophthalmol; 1999 Jul; 128(1):114-6. PubMed ID: 10482111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unifocal cervical Castleman disease in two children.
    Tuerlinckx D; Bodart E; Delos M; Remacle M; Ninane J
    Eur J Pediatr; 1997 Sep; 156(9):701-3. PubMed ID: 9296533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lenalidomide: a new treatment option for Castleman disease.
    Szturz P; Adam Z; Chovancová J; Stehlíková O; Klabusay M; Rehák Z; Koukalová R; Krejčí M; Pour L; Zahradová L; Hájek R; Mayer J
    Leuk Lymphoma; 2012 Oct; 53(10):2089-91. PubMed ID: 21902577
    [No Abstract]   [Full Text] [Related]  

  • 16. Rituximab as a Single Agent for Granulomatous Lymphocytic Interstitial Lung Disease in Common Variable Immune Deficiency.
    Tessarin G; Bondioni MP; Rossi S; Palumbo L; Soresina A; Badolato R; Plebani A; Lougaris V
    J Investig Allergol Clin Immunol; 2019 Dec; 29(6):470-471. PubMed ID: 31825316
    [No Abstract]   [Full Text] [Related]  

  • 17. Fulminant multicentric Castleman's disease in a patient with well-controlled human immunodeficiency virus infection-lessons from the patient.
    Chen TC; Tseng HH; Wong LC
    J Formos Med Assoc; 2018 Mar; 117(3):244-246. PubMed ID: 28666716
    [No Abstract]   [Full Text] [Related]  

  • 18. Dissecting idiopathic multicentric Castleman's disease.
    Dupin N
    Lancet Haematol; 2016 Apr; 3(4):e153-4. PubMed ID: 27063968
    [No Abstract]   [Full Text] [Related]  

  • 19. Extranodal Castleman disease of the extremities: a case report and review of the literature.
    Eward WC; DeWitt SB; Brigman BE; Kontogeorgakos V; Lagoo AS
    Skeletal Radiol; 2014 Nov; 43(11):1627-31. PubMed ID: 24970669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unicentric Castleman disease presenting as a retroperitoneal peripancreatic mass: A report of two cases and review of literature.
    Cheng JL; Cui J; Wang Y; Xu ZZ; Liu F; Liang SB; Tian H
    World J Gastroenterol; 2018 Sep; 24(34):3958-3964. PubMed ID: 30228787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.